Potassium supplementation inhibits IL-17A production induced by salt loading in human T lymphocytes via p38/MAPK-SGK1 pathway

Experimental and Molecular Pathology

Volumn 100, Issue 3, 2016, Pages 370-377

  Wen, Wen ^a   Wan, Zhaofei ^a   Ren, Keyu ^a   Zhou, Dong ^a   Gao, Qiyue ^a   Wu, Yan ^a   Wang, Lijun ^a   Yuan, Zuyi ^a,b   Zhou, Juan ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shaanxi Key Laboratory of Molecular Cardiology   (China)

Author keywords

High salt diet; IL 17A; P38 MAPK; Potassium supplementation; SGK1

Indexed keywords

INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM; POTASSIUM CHLORIDE; RNA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHLORIDE; IL17A PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ADULT; AGED; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; JURKAT CELL LINE; MOLECULAR MECHANICS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SALT INTAKE; SALT LOADING; SUPPLEMENTATION; T LYMPHOCYTE; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; BLOTTING, WESTERN; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERLEUKIN-17; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; POTASSIUM; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; T-LYMPHOCYTES;

EID: 84961916282     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2016.03.009     Document Type: Article

References (48)

1. Aburto N.J., Hanson S., Gutierrez H., Hooper L., Elliott P., Cappuccio F.P. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013, 346:f1378.
2. Baudrand R., Campino C., Carvajal C.A., Olivieri O., Guidi G., Faccini G., Vohringer P.A., Cerda J., Owen G., Kalergis A.M., Fardella C.E. High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin. Endocrinol. (Oxf) 2014, 80:677-684.
3. Brown I.J., Tzoulaki I., Candeias V., Elliott P. Salt intakes around the world: implications for public health. Int. J. Epidemiol. 2009, 38:791-813.
4. Chatterjee R., Colangelo L.A., Yeh H.C., Anderson C.A., Daviglus M.L., Liu K., Brancati F.L. Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetologia 2012, 55:1295-1303.
5. Chen S., Grigsby C.L., Law C.S., Ni X., Nekrep N., Olsen K., Humphreys M.H., Gardner D.G. Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents. J. Clin. Invest. 2009, 119:1647-1658.
6. Cheng X., Yu X., Ding Y.J., Fu Q.Q., Xie J.J., Tang T.T., Yao R., Chen Y., Liao Y.H. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 2008, 127:89-97.
7. Cohen H.W., Hailpern S.M., Fang J., Alderman M.H. Sodium intake and mortality in the NHANES II follow-up study. Am. J. Med. 2006, 119:275.e7-14.
8. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., O'Keefe J.H., Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81:341-354.
9. D'Elia L., Barba G., Cappuccio F.P., Strazzullo P. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J. Am. Coll. Cardiol. 2011, 57:1210-1219.
10. Ekinci E.I., Cheong K.Y., Dobson M., Premaratne E., Finch S., Macisaac R.J., Jerums G. High sodium and low potassium intake in patients with Type 2 diabetes. Diabet. Med. 2010, 27:1401-1408.
11. Ekinci E.I., Clarke S., Thomas M.C., Moran J.L., Cheong K., MacIsaac R.J., Jerums G. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011, 34:703-709.
12. Fang Y., Mu J.J., He L.C., Wang S.C., Liu Z.Q. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians. Hypertension 2006, 48:724-729.
13. Gaffen S.L. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr. Rheumatol. Rep. 2009, 11:365-370.
14. Gaffen S.L. Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 2011, 23:613-619.
15. Go W.Y., Liu X., Roti M.A., Liu F., Ho S.N. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10673-10678.
16. Gu D., Zhao Q., Chen J., Chen J.C., Huang J., Bazzano L.A., Lu F., Mu J., Li J., Cao J., Mills K., Chen C.S., Rice T., Hamm L.L., He J. Reproducibility of blood pressure responses to dietary sodium and potassium interventions: the GenSalt study. Hypertension 2013, 62:499-505.
17. He J., Ogden L.G., Vupputuri S., Bazzano L.A., Loria C., Whelton P.K. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999, 282:2027-2034.
18. He F.J., Li J., Macgregor G.A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346:f1325.
19. Honkanen J., Nieminen J.K., Gao R., Luopajarvi K., Salo H.M., Ilonen J., Knip M., Otonkoski T., Vaarala O. IL-17 immunity in human type 1 diabetes. J. Immunol. 2010, 185:1959-1967.
20. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149-162.
21. Junger W.G., Liu F.C., Loomis W.H., Hoyt D.B. Hypertonic saline enhances cellular immune function. Circ. Shock 1994, 42:190-196.
22. Kido M., Ando K., Onozato M.L., Tojo A., Yoshikawa M., Ogita T., Fujita T. Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension. Hypertension 2008, 51:225-231.
23. Kleinewietfeld M., Manzel A., Titze J., Kvakan H., Yosef N., Linker R.A., Muller D.N., Hafler D.A. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013, 496:518-522.
24. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
25. Liu F., Mu J., Yuan Z., Zhang M., Zheng S., Lian Q., Liu E., Xu H., Ren K., Huang Q. Potassium supplement ameliorates salt-induced haemostatic abnormalities in normotensive subjects. Acta Cardiol. 2011, 66:635-639.
26. Machnik A., Neuhofer W., Jantsch J., Dahlmann A., Tammela T., Machura K., Park J.K., Beck F.X., Muller D.N., Derer W., Goss J., Ziomber A., Dietsch P., Wagner H., van Rooijen N., Kurtz A., Hilgers K.F., Alitalo K., Eckardt K.U., Luft F.C., Kerjaschki D., Titze J. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 2009, 15:545-552.
27. Marks B.R., Nowyhed H.N., Choi J.Y., Poholek A.C., Odegard J.M., Flavell R.A., Craft J. Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 2009, 10:1125-1132.
28. Mei H., Rice T.K., Gu D., Hixson J.E., Jaquish C.E., Zhao Q., Chen J.C., Cao J., Li J., Kelly T.N., Rao D.C., He J. Genetic correlation of blood pressure responses to dietary sodium and potassium intervention and cold pressor test in Chinese population. J. Hum. Hypertens. 2011, 25:500-508.
29. Morimoto A., Uzu T., Fujii T., Nishimura M., Kuroda S., Nakamura S., Inenaga T., Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997, 350:1734-1737.
30. O'Donnell M.J., Yusuf S., Mente A., Gao P., Mann J.F., Teo K., McQueen M., Sleight P., Sharma A.M., Dans A., Probstfield J., Schmieder R.E. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011, 306:2229-2238.
31. Reynolds J.M., Angkasekwinai P., Dong C. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 2010, 21:413-423.
32. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., Simons-Morton D.G., Karanja N., Lin P.H. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med. 2001, 344:3-10.
33. Salker M.S., Christian M., Steel J.H., Nautiyal J., Lavery S., Trew G., Webster Z., Al-Sabbagh M., Puchchakayala G., Foller M., Landles C., Sharkey A.M., Quenby S., Aplin J.D., Regan L., Lang F., Brosens J.J. Deregulation of the serum- and glucocorticoid-inducible kinase SGK1 in the endometrium causes reproductive failure. Nat. Med. 2011, 17:1509-1513.
34. Shapiro L., Dinarello C.A. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:12230-12234.
35. Taleb S., Tedgui A., Mallat Z. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler. Thromb. Vasc. Biol. 2015, 35:258-264.
36. Thomas M.C., Moran J., Forsblom C., Harjutsalo V., Thorn L., Ahola A., Waden J., Tolonen N., Saraheimo M., Gordin D., Groop P.H. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
37. Tuomilehto J., Jousilahti P., Rastenyte D., Moltchanov V., Tanskanen A., Pietinen P., Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001, 357:848-851.
38. Vallon V., Wulff P., Huang D.Y., Loffing J., Volkl H., Kuhl D., Lang F. Role of Sgk1 in salt and potassium homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R4-10.
39. Vedovato M., Lepore G., Coracina A., Dodesini A.R., Jori E., Tiengo A., Del P.S., Trevisan R. Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia 2004, 47:300-303.
40. Whelton P.K., He J., Cutler J.A., Brancati F.L., Appel L.J., Follmann D., Klag M.J. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997, 277:1624-1632.
41. WHO Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988, 297:319-328.
42. WHO Diet, nutrition and the prevention of chronic diseases. World Health Organ. Tech. Rep. Ser. 2003, 916:i-viii. (1-149, backcover).
43. Wu C., Yosef N., Thalhamer T., Zhu C., Xiao S., Kishi Y., Regev A., Kuchroo V.K. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
44. Wulff P., Vallon V., Huang D.Y., Volkl H., Yu F., Richter K., Jansen M., Schlunz M., Klingel K., Loffing J., Kauselmann G., Bosl M.R., Lang F., Kuhl D. Impaired renal Na(+) retention in the sgk1-knockout mouse. J. Clin. Invest. 2002, 110:1263-1268.
45. Yamaguchi Y., Fujio K., Shoda H., Okamoto A., Tsuno N.H., Takahashi K., Yamamoto K. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J. Immunol. 2007, 179:7128-7136.
46. Zeng C., Shi X., Zhang B., Liu H., Zhang L., Ding W., Zhao Y. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J. Mol. Med. (Berl) 2012, 90:175-186.
47. Zhao Z., Wu Y., Cheng M., Ji Y., Yang X., Liu P., Jia S., Yuan Z. Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome 2011, 518-524.
48. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.